R&D An AAPS PharmSci 360 overview: Making better decisions faste... This year's AAPS PharmSci 360 focused on how we make better decisions faster, earlier, and with fewer resources.
News AZ's Alexion extends gMG options with two Klygefa approvals AstraZeneca's Alexion unit has won approval in the US and EU for Klygefa, billed as a future blockbuster, for generalised myasthenia gravis (gMG).
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.